Larvol Delta - Phase-I-interim-results-of-a-phase-III-study-of-the-IgGFc-fusion-COVID19-subunit-vaccine-AKS452

AKS-452 - Akston

http://www.ncbi.nlm.nih.gov/pubmed/35115195

Feb 5, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next